Lok Sabha Question No. 779 (UNSTARRED), answered on 2021-07-23
Subject: ACCR Portal
Ministry: AYURVEDA,YOGA & NATUROPATHY,UNANI,SIDDHA AND HOMEOPATHY (AYUSH)
Asked by: Dipsinh Shankarsinh Rathod, Anil Firojiya, Mohanbhai Kalyanji Kundariya

## GOVERNMENT OF INDIA MINISTRY OF AYURVEDA, YOGA & NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY (AYUSH)

LOK SABHA UNSTARRED  QUESTION NO. 779 TO BE ANSWERED ON 23 RD JULY , 2021

## ACCR PORTAL

## 779. SHRI DIPSINH SHANKARSINH RATHOD: SHRI ANIL FIROJIYA: SHRI MOHANBHAI KALYANJI KUNDARIYA:

Will the Minister of AYUSH be pleased to state:

- (a) whether the Government has introduced Ayush Clinical Case Repository (ACCR) Portal and Ayush Sanjivani App to benefit doctors and common people, if so, the details thereof;
- (b) whether the Ministry has formulated any plan to preve t Corona;
- (c) if so, the details thereof; and
- (d) if not, the reasons therefor?

## ANSWER

## THE MINISTER OF STATE OF THE MINISTRY OF AYURVEDA, YOGA & NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY (DR. MUNJPARA MAHEND RABHAI)

- (a): Yes. Ministry of Ayush has launched Ayush Clinical Case Repository (ACCR) Portal and Ayush Sanjivani App version 3.0 on 27.05.2021.

Ayush Clinical Case Repository Portal (ACCR) - This portal will facilitate the posting of success stories/successfully treated cases by Ayush practitioners. These cases will hel practitioners  to  know  approaches  adopted  by  their  colleagues  in  th treatment  of  various patients. The public can also go through these cases and understand the strengths of Ayush systems in the treatment of various ailments/diseases and adopt informed choice the treatment as and when required.

Ayush Sanjiv ani App - Ayush Sanjivani App version 1.0 has helped in documenting the impact assessment of effectiveness, acceptance and usage of Ayush advisories & measure the prevention of COVID - 19  through  the  Mobile  app  base  population  study  in  around  1.5 crores  re spondents.  85.1%  of  the  respondents  reported  the  use  of  Ayush  measures  for  t prevention of COVID - 19, among which 89.8% of respondents agreed to have benefitted from the practice of Ayush advisory.

The  current  version  has  been  launched  for  collecting  da ta  related  to  the  study  on AYUSH - 64 and Kabasura Kudineer through Research Councils and National Institute unde the Ministry of Ayush across the country.

(b) : Yes. (c) : Details are at Annexure I (d) : Does not arise.

1. On 29.01.2020The Ministry of Ayush issued an advisory on protecting yourself from COVID and staying healthy. In the advisory, in addition to maintaining hygiene like wash, use of mask etc. simple home remedies were also suggested for people.
2. On 06.03.2020 A lette r to all Chief Secretaries of States / Union territories was from the Ministry with more specific suggestions on augmentation of General Immuni of people and possible Ayush intervention wherever required in coordination with He departments of th e States / UTs.
3. On 16.03.2020 A letter was sent to the Ministry of Health & Family welfare offering integrate and utilize huge Ayush infrastructure to combat the COVID - 19 pandemic.
4. On 23.03.2020 Ministry  has  sent  a  D.O.  letter  to  Principals  of  all  Ayu rveda, Siddha, Unani and Homoeopathy (ASU&H) colleges (approximately 727 colleges) for utilization of  available  infrastructure  facilities  like  Hospital  (IPD  &  OPD),  pathology  labo ICU and manpower including medical & Paramedical Staff to combat wit h the COVID19 pandemic. Therefore, they were requested to offer their services to local health aut for utilization of the available facilities by them as per the situation arises. A the various Ayush institutes hospital were utilized by State Governments and designated as quarantine centre, isolation centre, Covid care centre and Covid health centre.
5. On 23.03.2020 A D.O. Letter from Secretary, Ayush was sent to Secretary DHR & DG ICMR to initiate research for Ayush leads to deal with Cor ona Pandemic.
6. On 31.03.2020 The Ministry uses platforms like video conferencing and social media t reach out to Ayush practitioners and involve them in stopping and discouraging fals unsupported claims.
7. On  31.03.2020 Ministry  of  Ayush  recommends  se lf - care  guidelines  for  preventive health measures and boosting immunity with special reference to respiratory health.
- i. General Measures
- ii. Ayurvedic Immunity Promoting Measures
- iii. Simple Ayurvedic Procedures
- iv. During dry cough/sore throat
12. 8 . Ministry of Ayush and MoHFW have jointly provided training to 33,000 Ayush master trainers. Total 66045 AYUSH Personnel had obtained training at igot.in platform o a continual basis. Ministry of Ayush has coordinated with MoHFW for utilisation of Ay manpower as COVID warrior to manage COVID -19 with identified roles.
9. On  02.04.2020 The Ministry  of  Ayush  has  formed  an  Interdisciplinary  Ayush  R&D Task  Force  chaired  by  Prof.  Bhushan Patwardhan  and  having  representation  from scientists including ICMR , DBT, CSIR, AIIMS and AYUSH Institutions. The Interdisciplinary  Ayush  Research  and  Development  Task  Force  has  formulated  and designed clinical research protocols for prophylactic studies and add - on interventions in COVID - 19  positive  cases  through a thoro ugh  review  and  consultative  process  of  high repute experts from different organizations across the country for studying four d interventions  viz.  Ashwagandha,  Yashtimadhu,  Guduchi  +  Pippali  and  a polyherbal formulation (AYUSH - 64).
10. On 21.04. 2020Ministry of Ayush issued Gazette notification for undertaking resear on  COVID - 19  through  Ayurveda,  Siddha,  Unani  and  Homeopathy  Systems  including prophylactic measures, intervention during the quarantine, asymptomatic a symptomatic cases of COVID - 19, Public Health Research, Survey, Lab Based Research etc. to generate evidence.

Ayu

Ministry of Ayush has also launched interdisciplinary studies involving interventions  for  COVID - 19  based  on  Task  force  recommendations.  Under  various research organizations and National Institutes under the Ministry of Ayush, 126 rese studies at approx. 152 centres in the country have been initiated on Ayush interve Ministry  of  Ayush  has  also  taken  initiatives  to  conduct  clinical  studies  on  Ayu medicine with countries like USA, Brazil, South Africa, Ghana, UK, Germany etc.

11. On  31.05.2020 Guidelines  for  Registered  Practitioners  of  respective  system  of  Ayu have been prepared by Director Generals of Research Councils and Directors of Natio l Institutes with their team of experts and same is vetted by the Inter - disciplinary Ayush Research and Development Task Force of Ministry of Ayush. These guidelines are made available  in  the  public  domain  to  benefit  registered  Ayush  practitioners  incl g Homoeopathy to help in the management of COVID 19 pandemic uniformly.
12. On 28.07.2020 In order to make the process of product approval/licensing consistent State/UT level for effective quality control of Ayurvedic, Siddha, Unani Homeopathic  medicines  underwent  clinical  trials/research  studies  for  COVID - 19, Ministry directed to all State/UT Licensing Authorities to forward license applica such  formulations  with  details  and  results  of  the  clinical  trial/research  st verification by the Central Government in the Ministry of Ayush and also directed that State/UT Licensing Authorities shall grant the approval or license to manufacture f of any such formulation only after obtaining clearance from the Central Government.
13. On 14.08.2020 The Ministry of Ayush launched a three -month campaign on 'Ayush for Immunity', through webinar and publishing a campaign bulletin on Ayush for Immunity. More than 50 thousand people participated in the Webinar.
14. On 06.10.2020 The Gove rnment of India has released 'National Clinical Management Protocol based on Ayurveda and Yoga for management of COVID -19' prepared by theNational Task force which consensus from various expert committees.
5. 15 . Ministry of Ayush has also constituted core group of experts under the Chairmanship of Prof. Bhushan Patwardhan to identify and propose formulations on COVID - 19 which are in line with Classical Ayurveda principles and have substantial leads on COVID - 19 viz. one for prophylaxis as immunomodulato ry, another for management of COVID - 19 with antiviral properties and one product for post COVID - 19 care.
16. On  26.04.2021 Ministry  of  Ayush  has  also  released  Ayurveda,  Unani  and  Siddha preventive  measures  for  self -care  during  COVID - 19 and  Guidelines f or  Ayush Practitioners for COVID -19 Patients in Home Isolation.
17. On 27.04.2021 -Ministry of Ayush has also issued an advisory for Ayush practitioners ethical practices during Covid 19 pandemic.
18. On 30.04.2021 Ministry of Ayush vide its D.O. letter no. Y - 18020/2/2020 -EP - III has requested all States/UTs to issue appropriate instructions to District Authorities to involve District Ayurveda Officers in the management and mitigation of Covid - 19 in the districts and utilize the services of Ayush doctors, Ayush healthcare providers and Ayush  health  care  facilities  extensively  so  that  the  shortage  of  manpower infrastructure for the management of Covid - 19 can be duly addressed.
19. Ministry  of  Ayush  has  issued  guidelines  for  Registere d  Practitioners  of  respective system s of  AYUSH.  These  guidelines  have  been  prepared  by  Director  Generals  of Research Councils and  Directors of National  Institutes with their team  of expert same is vetted by the Interdisciplinary AYUSH Research and Dev elopment Task Force of Ministry  of  AYUSH.  These  guidelines  are  made  available  in  public  domain  for  th benefit  of  registered  AYUSH  practitioners  to  help  in  the  management  of  COVID  19 pandemic uniformly.
20. On 27.04.2021 -States/ UTs licensing authorities / Drug Controllers has been informed to allow the licensed manufactures for AYUSH - 64 under their jurisdiction to include a new indication  of  AYUSH - 64  for  repurposing  as  an  intervention  for  the  management  of asymptomatic, mild to moderate COVID - 19 in addition to existing indication (s). Further States/  UTs  Licensing  Authorities  have  been  requested  to  expedite  the  process  of licensing/ approval of the application for the manufacturing of AYUSH - 64.
21. On 03.05.2021, Ministry of Ayush vide D.O letter no.S - 16030/13/3030 - NAM has also requested  the  States/UTs  Governments  to  popularise  the  use  of Kabasurakudineer and AYUSH - 64  in  the  asymptomatic,  mild  to  moderate  COVID - 19  patients  at  isolation centres/  Covid  Care  Centre  /  Covid  Health  Centre,  A yush  hospitals/  dispensary  and patients in home isolation.
22. On 07.05.2021 -In order to provide a maximum benefit of Ayush systems of medicine, a Nation - wide campaign for the distribution of AYUSH - 64 and Kabasura Kudineer through  Research  Councils  and National  Institute  under  Ministry  of  Ayush across the country.
23. On  07.05.2021 ,  for  continuing  with  the  efforts  to  augment  human  resources  for  t management of COVID-19 cases, the Ministry of Ayush has issued an advisory to deplo the  trained  Ayush human  resources  available  with  them  for  clinical  management  of COVID - 19 cases.
24. Ministry of AYUSH has released Home care guidelines for children and Advisory fo AYUSH  Practitioners  about  prophylactic  care  in  Children  during  the  COVID - 19 Pandemic.
25. Ayush COVID Counselling Helpline 14443 has been launched.
26. Central  Council  for  Research  in  Ayurvedic  Sciences has  undertaken 12  prophylactic studies on  Ayurvedic  interventions  for  prophylaxis  of  COVID - 19.  Details  are  at Annexure-II.

## Ayurvedic interventions for prophylaxis of COVID - 19

|   S. No. | Study title                                                                                                                                                                                                                                            | Study Centre                                                      | Study Intervention                              | Status                                                                           |
|----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------|-------------------------------------------------|----------------------------------------------------------------------------------|
|        1 | Evaluation of protective potential AyurvedicRasayan (Chyawanprash) the prevention of COVID - 19 among HealthCare Personnel - An open label, prospective Randomized controlled parallel group study                                                     | of an in Chaudhary Brahm Prakash AyurvedCharakSansthan, New Delhi | Chyawanprash                                    | Study Completed. https://www.medrxiv.org/content /10.1101/2021.02.17.21251899v 2 |
|        2 | Evaluation of the efficacy of an Ayurvedic intervention (Chyawanprash) in the prevention COVID - 19 pandemic among Health Care Personnel - An open label single arm prospective study                                                                  | of Ayurvedic& Unani Tibbia College, New Delhi                     | Chyawanprash                                    | Study Completed.                                                                 |
|        3 | Impact of Ayurvedic Interventions prevention of COVID - 19 infection identified containment area of                                                                                                                                                    | in in Delhi Central Ayurveda Research Institute, New Delhi        | GuduchiGhanVati/ Ashwagandha/ SudarshanGhanVati | Study Completed.                                                                 |
|        4 | A prospective non - randomized open label controlled interventional study the effect of GuduchiGhanVati/ SudarshanGhanVati as a prophylactic measure among high risk population (Health Care Workers/ Containment Zone population) exposed to COVID 19 | on 15 CCRAS institutes                                            | GuduchiGhanVati/ SudarshanGhanVati              | Study Completed.                                                                 |
|        5 | Impact of Ayurvedic intervention (GuduchiGhanvati) in the containment                                                                                                                                                                                  | Regional Ayurveda Research Institute, Mandi                       | GuduchiGhanvati                                 | Study Completed.                                                                 |

## Annexure II

<!-- image -->

|    | areas of Himachal Pradesh -a community- based study                                                                                                                                                                                                   |                                                                |                                                                                           | https://osf.io/8vwsy   |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------|-------------------------------------------------------------------------------------------|------------------------|
|  6 | A prospective non - randomized open labeled controlled interventional on the effect of Ashwagandha ( Withaniasomnifera ) as a prophylactic measure among high risk population (Health Care Workers/Containment Zone Population) exposed to COVID - 19 | study National Institute of Medical Heritage, Hyderabad        | Indian Ashwagandha                                                                        | Study Completed.       |
|  7 | A prospective non - randomized open labeled controlled interventional on the effect of Guduchi ( Tinosporacordifolia ) as a prophylactic measure among high population (Health Care Workers/Containment Zone Population) exposed to COVID - 19        | study risk National Institute of Medical Heritage, Hyderabad   | Indian Guduchi                                                                            | Study Completed.       |
|  8 | A prospective non- randomized open labeled controlled interventional on the effect of ChyavanprashLehyam as a prophylactic measure among risk population (Health Care Workers/Containment Zone Population) exposed to COVID - 19                      | study high National Institute of MedicalHeritage, Hyderabad    | Indian Chyavanprash                                                                       | Study Completed.       |
|  9 | Prospective non randomized open label control interventional the effect of AyurvedicRaksha (Chyavanprash, Samsahmanivati&Haritaki) as Prophylactic measure among police                                                                               | study on Kit National Institute of Medical Heritage, Hyderabad | Indian AyurvedicRaksha Kit (Chyavanprash, Haritaki and Samsahmanivati containing Guduchi) | Study Completed.       |

|    | personal working in the vicinity COVID - 19 facilities                                                                                                                                                                                           | of                                                                                                                                                                              |                                                                                               |                  |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|------------------|
| 10 | Prospective non randomized open label control interventional study the effect of AyurvedicRaksha - 1 (Ayush 64, Samsahmanivati&Chyavanprash) as Prophylactic measure among Ayush healthcare workers working in vicinity of COVID - 19 facilities | on Kit the National Institute of Medical Heritage, Hyderabad                                                                                                                    | Indian AyurvedicRaksha Kit - 1 (Ayush 64, Chyavanprash and Samsahmanivati containing Guduchi) | Study Completed. |
| 11 | A Study of Ashwagandha in the Prophylaxis Against COVID - 19 and its benefits on General Health Risk Health Care Workers: A Randomized Controlled Comparison with Hydroxychloroquine Sulphate (HCQS)                                             | in High DattaMeghe Institute of Medical Sciences, Wardha; Central Ayurveda Research Institute, Mumbai; Sri DharmasthalaManjunathes hwara College of Ayurveda & Hospital, Hassan | Ashwagandha                                                                                   | Study Completed. |
| 12 | A prospective open label controlled interventional study on the Ayurvedic intervention (Ayurveda Raksha Kit) as a prophylactic measure in the Pandemic of COVID - 19 -A community based study                                                    | effect of Through 20 CCRAS institutes under S chedule Caste Sub - Plan project                                                                                                  | Ayurveda Raksha Kit (Chyavanprash, Ayush Kwatha, Samshamanivaticontai ning Guduchi, AnuTaila) | Study Completed. |